ALBIX
LIVE

Serial Number

79141004

Owner

Albumedix Ltd

Filing Date

Oct 9, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ALBIX Trademark

Serial Number: 79141004 • Registration: 4607782

ALBIX is a trademark filed by Albumedix Ltd on October 9, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Albumedix Ltd (16 trademarks)

HQ, Mabel Street

Entity Type: 99

ALBUMEDIX A/S (13 trademarks)

LOTTENBORGVEJ 26
LYNGBY , DK

Entity Type: 11

NOVOZYMES BIOPHARMA DK A/S (8 trademarks)

KrogshĂžjvej 36

Entity Type: 99

Trademark Details

Filing Date

October 9, 2013

Registration Date

September 23, 2014

Published for Opposition

July 8, 2014

Cancellation Date

October 8, 2023

Goods & Services

Pharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents

[ Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; ] albumin for use in the manufacture of pharmaceuticals, vaccines, medical substances and cell therapy preparations; chemical substances for use in diagnostic kits, namely, albumin blocking agents used to bind to test kit surfaces to prevent non-specific binding of test substances to the surface [ ; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations ]

Scientific and technological research and development services for new products and uses in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; consultancy services regarding product research and product development in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cell research; advisory services with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; providing expert analysis with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cells * in the field of development of medicines and pharmaceutical products *; and scientific development and analysis in the fields of pharmaceuticals, vaccines, and drug discoveries; all relating to * the use of albumin in * science, biotechnology, biochemistry, biology, medicine and pharmaceuticals

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 6, 2024 DENC
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 6, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 6, 2024 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2023 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 4, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 22, 2022 INTS
INVALIDATION PROCESSED
Apr 22, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 9, 2021 INTR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 23, 2021 ADCH
CANCELLED SECTION 71
Apr 9, 2021 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Jan 23, 2020 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 23, 2019 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 14, 2019 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 24, 2019 NREP
CHANGE OF OWNER RECEIVED FROM IB
Oct 11, 2018 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 1, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jul 13, 2017 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 9, 2016 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 28, 2016 INPR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 27, 2016 TCCA
CORRECTION UNDER SECTION 7 - PROCESSED
Feb 28, 2016 COC.
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2016 NREP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Feb 24, 2016 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Feb 19, 2016 LIMG
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 22, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 22, 2015 REAP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Aug 20, 2015 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 20, 2015 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 20, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 27, 2015 FICS
FINAL DISPOSITION PROCESSED
Feb 27, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 23, 2014 FICR
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 19, 2014 COC.
ASSIGNED TO PARALEGAL
Nov 19, 2014 PLGL
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 19, 2014 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Oct 30, 2014 LIMG
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2014 R.PR
NOTIFICATION PROCESSED BY IB
Jul 22, 2014 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jul 8, 2014 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 2, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 2, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 5, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
May 27, 2014 XAEC
ASSIGNED TO LIE
May 27, 2014 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 26, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
May 26, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 26, 2014 CNEA
REFUSAL PROCESSED BY IB
Feb 22, 2014 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2014 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2014 RFCS
REFUSAL PROCESSED BY MPU
Feb 3, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 1, 2014 RFCR
NON-FINAL ACTION WRITTEN
Jan 31, 2014 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 14, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2014 REPR